Close
Home - Press releases - Hélène Moore appointed Head of Ethypharm Digital Therapy with responsibility for building a European Leader in this innovative field.

Do you have
any question?

Contact us
06/05/2021

Hélène Moore appointed Head of Ethypharm Digital Therapy with responsibility for building a European Leader in this innovative field.

Saint-Cloud, France – May 6th, 2021 – One month after the acquisition of the exclusive rights for two innovative digital therapies in the Central Nervous System, deprexis® and vorvida®, Ethypharm announces the establishment of a new business unit, Ethypharm Digital Therapy SAS, and the appointment of Hélène Moore as Executive Vice-President (EVP) and Head of the entity.

Press release

Media enquiries

Please provide a valid state.
Please provide a valid state.
Please provide a valid state.
(+)
Please provide a valid state.
Please provide a valid state.
Please provide a valid state.
*All fields must be filled in

Thank you for your message!
We will examine it with utmost attention and get back to you shortly.